2006 Rho Chi Lecture: Unparalleled opportunities for improving medication-related health outcomes.
作者信息
Nahata Milap C
机构信息
College of Pharmacy, Ohio State University, Parks Hall, 500 W 12th Avenue, Columbus, OH 43210, USA.
出版信息
Am J Pharm Educ. 2006 Aug 15;70(4):80. doi: 10.5688/aj700480.
Abstract
摘要
相似文献
1
2006 Rho Chi Lecture: Unparalleled opportunities for improving medication-related health outcomes.
Am J Pharm Educ. 2006 Aug 15;70(4):80. doi: 10.5688/aj700480.
2
Artificial Intelligence in Health Care: A Report From the National Academy of Medicine.《医疗保健中的人工智能：美国国家医学院的一份报告》
JAMA. 2020 Feb 11;323(6):509-510. doi: 10.1001/jama.2019.21579.
3
Less Health Care, More Health: The Inverse U of Medical Spending and Health in the United States.医疗保健减少，健康增加：美国医疗支出与健康的倒U型关系
Am J Public Health. 2020 Dec;110(12):1755-1757. doi: 10.2105/AJPH.2020.305981.
4
It is important to distinguish CER from patient-centered outcomes research. Introduction.区分成本效果分析（CER）与以患者为中心的结局研究很重要。引言。
J Manag Care Pharm. 2012 May;18(4 Suppl A):S3-4. doi: 10.18553/jmcp.2012.18.S8-A.S03.
5
ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.美国卫生系统药师协会关于预防化疗和生物治疗用药错误的指南。
Am J Health Syst Pharm. 2015 Apr 15;72(8):e6-e35. doi: 10.2146/sp150001.
6
Why Did Cross-National Divergences in Life Expectancy and Health Care Expenditures Both Appear in the 1980s?为何预期寿命和医疗保健支出的跨国差异均出现在20世纪80年代？
Am J Public Health. 2020 Dec;110(12):1741-1742. doi: 10.2105/AJPH.2020.305909.
7
Transforming Health Care to Address Value and Equity: National Vital Signs to Guide Vital Reforms.转变医疗保健以实现价值与公平：指导重大改革的国家关键指标
JAMA. 2021 Jul 13;326(2):131-132. doi: 10.1001/jama.2021.9938.
8
Institute of medicine recommendations for improving the quality of cancer care: what do they mean for the general internist?医学研究所关于提高癌症护理质量的建议：对普通内科医生而言意味着什么？
J Gen Intern Med. 2014 Oct;29(10):1404-9. doi: 10.1007/s11606-014-2931-9. Epub 2014 Jun 21.
9
APhA drug treatment protocols support clinical decision-making and patient care.
J Am Pharm Assoc (Wash). 1997 Sep-Oct;NS37(5):503-6. doi: 10.1016/s1086-5802(16)30260-1.
10
Enhancing drug evaluation in diverse populations and older adults: National Academies of Sciences, Engineering, and Medicine considerations.加强不同人群和老年人的药物评估：美国国家科学院、工程院和医学院的考量因素
J Am Geriatr Soc. 2024 Sep;72(9):2912-2920. doi: 10.1111/jgs.19075. Epub 2024 Jul 17.
引用本文的文献
1
Development and evaluation of a required patient safety course.一门必修患者安全课程的开发与评估
Am J Pharm Educ. 2008 Jun 15;72(3):65. doi: 10.5688/aj720365.
本文引用的文献
1
Role of pharmacist counseling in preventing adverse drug events after hospitalization.药师咨询在预防住院后药物不良事件中的作用。
Arch Intern Med. 2006 Mar 13;166(5):565-71. doi: 10.1001/archinte.166.5.565.
2
Kaiser Permanente Colorado Region Pharmacy Department: innovative leader in pharmacy practice.凯撒医疗科罗拉多地区药房：药学实践的创新领导者。
J Am Pharm Assoc (2003). 2006 Jan-Feb;46(1):67-76. doi: 10.1331/154434506775268580.
3
ASHP national survey of pharmacy practice in hospital settings: dispensing and administration--2005.美国卫生系统药师协会医院药学实践全国性调查：调配与给药——2005年
Am J Health Syst Pharm. 2006 Feb 15;63(4):327-45. doi: 10.2146/ajhp050538.
4
Advancing patient care through innovative practice: the Clinical Partners Program.通过创新实践推进患者护理：临床合作伙伴计划。
Am J Health Syst Pharm. 2005 Dec 1;62(23):2501-7. doi: 10.2146/ajhp050017.
5
The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know.药物依从性对改善慢性病相关结局的重要性：我们已知的和需要进一步了解的内容。
Med Care. 2005 Jun;43(6):517-20. doi: 10.1097/01.mlr.0000166617.68751.5f.
6
ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.美国卫生系统药师协会医院药学实践全国调查：处方开具与抄写——2004年
Am J Health Syst Pharm. 2005 Feb 15;62(4):378-90. doi: 10.1093/ajhp/62.4.0378.
7
OSF healthcare's journey in patient safety.OSF医疗集团在患者安全方面的历程。
Qual Manag Health Care. 2004 Jan-Mar;13(1):53-9. doi: 10.1097/00019514-200401000-00005.
Zotero 插件